Prasanna Kandel

Title: Prasanna Kandel: Innovator in Neurogenesis Research

Introduction

Prasanna Kandel is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of neurogenesis through his innovative research and patent work. His dedication to advancing medical science is evident in his focus on neurological disorders.

Latest Patents

Kandel holds a patent for "Small-molecule modulators of the orphan nuclear receptor TLX." This patent discloses small molecules that act through the ligand binding domain of nuclear receptor TLX (NR2E1). The invention aims to promote neurogenesis and treat disorders associated with nuclear receptor TLX, including Alzheimer's disease. The patent also provides compounds according to a specific formula, along with pharmaceutically acceptable salts or isomers thereof. He has 1 patent to his name.

Career Highlights

Prasanna Kandel is affiliated with the Baylor College of Medicine, where he conducts his research. His work is pivotal in understanding and addressing neurological disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Kandel collaborates with esteemed colleagues, including Fatih Semerci and Srinivas Chamakuri. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Prasanna Kandel's innovative work in neurogenesis and his patent contributions reflect his dedication to addressing critical health challenges. His research continues to pave the way for potential treatments for neurological disorders.